Dr. Truong is the Chair and Associate Professor of Radiation Oncology at BUSM and Chief of Radiation Oncology at Boston Medical Center. She received her medical degree from the University of New South Wales, Sydney Australia and completed her residency in Radiation Oncology at New York University Medical Center, her last year as chief resident. She is board certified in Radiation Oncology by the American Board of Radiology. Her specialties include the treatment of head and neck, skin and central nervous system malignancies, as well as benign diseases, including Airway Amyloidosis. Dr. Truong serves on a number of national committees including the Scientific Committee of the American Society for Therapeutic Radiation Oncology (ASTRO), on the head and neck and skin examination committee of the American Board of Radiology (ABR), and currently serves in NRG Oncology (National Surgical Adjuvant Breast and Bowel Project (NSABP), the Radiation Therapy Oncology Group (RTOG), and the Gynecologic Oncology Group (GOG)) as the Quality of Life Head and Neck Liaison. She is the Quality of Life Co-Chair on three national head and neck cancer multicenter trials conducted by the NRG Oncology group. She contributes her radiation expertise to the National Cancer Institute’s Adult Oncology Treatment editorial board. She also leads the Cyberknife Radiosurgery program for head and neck malignancies and brain tumors. She is actively involved in promoting clinical research activities at Boston Medical Center, and was awarded funding as Principal Investigator for an American Cancer Society/Boston University Institutional Grant for the investigation of novel function imaging in head and neck cancer using CT perfusion Imaging in Patients with Head and Neck Cancer undergoing Conformal Radiotherapy. Dr. Truong has also contributed to several Boston Medical Center funded research efforts including two U.S. Army Medical Research and Material Command Office Center of Excellence Program Projects and is a project principal investigator of a department of defense funded study investigating the role of stereotactic body radiotherapy for recurrent head and neck cancer.
Head and Neck Cancer
Skin Cancer, Cutaneous T Cell Lymphomas
Central Nervous System Malignancies
Radiotherapy for Airway Amyloidosis
Radiotherapy for Benign Diseases
Stereotactic Radiosurgery and Stereotactic Body Radiotherapy
Intensity Modulated Radiotherapy
Image Guided Radiotherapy
- Chair, Radiation Oncology, Boston University School of Medicine
- Chief, Radiation Oncology, Boston Medical Center
- University of New South Wales, MBBS
- University of New South Wales, BSc
- Published on 10/31/2018
Abbott JL, Qureshi MM, Truong MT, Sahni D. Comparing survival outcomes in early stage desmoplastic melanoma with or without adjuvant radiation. Melanoma Res. 2018 Oct 31. PMID: 30383720.
- Published on 9/24/2018
Tsai A, Buch K, Fujita A, Qureshi MM, Kuno H, Chapman MN, Li B, Oda M, Truong MT, Sakai O. Using CT texture analysis to differentiate between nasopharyngeal carcinoma and age-matched adenoid controls. Eur J Radiol. 2018 Nov; 108:208-214. PMID: 30396657.
- Published on 7/24/2018
Yan SX, Qureshi MM, Suzuki K, Dyer M, Truong MT, Litle V, Mak KS. Definitive treatment patterns and survival in stage II non-small cell lung cancer. Lung Cancer. 2018 Oct; 124:135-142. PMID: 30268452.
- Published on 6/20/2018
Truong MT, Grillone G. Reluctant Induction Followed by Proton Beam Therapy, If Practicable. Int J Radiat Oncol Biol Phys. 2018 Jul 15; 101(4):761. PMID: 29976481.
- Published on 6/11/2018
Royce TJ, Qureshi MM, Truong MT. Radiotherapy Utilization and Fractionation Patterns During the First Course of Cancer Treatment in the United States From 2004 to 2014. J Am Coll Radiol. 2018 Nov; 15(11):1558-1564. PMID: 29903550.
- Published on 6/11/2018
Copperman TS, Truong MT, Berk JL, Sobel RK. External beam radiation for localized periocular amyloidosis: a case series. Orbit. 2018 Jun 11; 1-7. PMID: 29889595.
- Published on 6/1/2018
Rubin SJ, Gurary EB, Qureshi MM, Salama AR, Ezzat WH, Jalisi S, Truong MT. Stage II Oral Tongue Cancer: Survival Impact of Adjuvant Radiation Based on Depth of Invasion. Otolaryngol Head Neck Surg. 2018 Jun 01; 194599818779907. PMID: 29944460.
- Published on 5/19/2018
Singh B, Qureshi MM, Truong MT, Sahni D. Optimal Surgical Modality for Early Merkel Cell Carcinoma-Results from the National Cancer Data Base. J Am Acad Dermatol. 2018 May 19. PMID: 29787838.
- Published on 2/8/2018
Kirke DN, Qureshi MM, Kamran SC, Ezzat W, Jalisi S, Salama A, Everett PC, Truong MT. Role of adjuvant chemoradiotherapy in T4N0 stage IV head and neck cancer: A National Cancer Database analysis. Head Neck. 2018 Jun; 40(6):1174-1184. PMID: 29417687.
- Published on 2/3/2018
Singh B, Qureshi MM, Truong MT, Sahni D. Demographics and outcomes of stage I and II Merkel cell carcinoma treated with Mohs micrographic surgery compared with wide local excision in the National Cancer Database. J Am Acad Dermatol. 2018 Jul; 79(1):126-134.e3. PMID: 29408552.
View 50 more publications: View full profile at BUMC